Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Galmed shares surged after announcing a new brain-penetrating formulation for treating Parkinson's.

flag Galmed Pharmaceuticals shares surged after announcing a new brain-penetrating formulation of its drug Aramchol. flag Developed with Barcode Nanotech, this innovation uses lipid nanoparticles to cross the blood-brain barrier, potentially treating Parkinson's disease and dementia. flag Preclinical studies showed the drug reduces alpha-synuclein aggregation, and the company plans to begin clinical trials in 2026.

3 Articles